| Literature DB >> 36242010 |
Matthias Peter Hilty1,2, Emanuele Favaron3, Pedro David Wendel Garcia4, Yavuz Ahiska5, Zuhre Uz6, Sakir Akin7, Moritz Flick8, Sesmu Arbous6, Daniel A Hofmaenner4, Bernd Saugel8, Henrik Endeman3, Reto Andreas Schuepbach4, Can Ince3.
Abstract
BACKGROUND: The sublingual microcirculation presumably exhibits disease-specific changes in function and morphology. Algorithm-based quantification of functional microcirculatory hemodynamic variables in handheld vital microscopy (HVM) has recently allowed identification of hemodynamic alterations in the microcirculation associated with COVID-19. In the present study we hypothesized that supervised deep machine learning could be used to identify previously unknown microcirculatory alterations, and combination with algorithmically quantified functional variables increases the model's performance to differentiate critically ill COVID-19 patients from healthy volunteers.Entities:
Keywords: Artificial intelligence; COVID-19; Deep learning; Microcirculation; Neuronal network
Mesh:
Year: 2022 PMID: 36242010 PMCID: PMC9568900 DOI: 10.1186/s13054-022-04190-y
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 19.334
Characteristics of the critically ill COVID-19 patients and healthy volunteers included in the present study
| Training and internal validation cohort | External validation cohort | |||||
|---|---|---|---|---|---|---|
| COVID-19 patients (Zurich / Rotterdam/The Hague cohorts) | Healthy volunteers (Hamburg cohort) | COVID-19 patients (Leiden cohort) | Healthy volunteers (Zurich cohort) | |||
| Age | 59.5 ± 10.6 | 24.1 ± 1.8 | < 0.0001 | 60.8 ± 10.7 | 45.8 ± 12.1 | < 0.0001 |
| Sex [male] | 43/54 (80%) | 17/40 (42.5) | < 0.0001 | 18/25 (72%) | 15/33 (55%) | < 0.0001 |
| Body mass index [kg m−2] | 29.0 ± 6.0 | 22.8 ± 2.9 | < 0.0001 | 30.0 ± 6.0 | 23.1 ± 4.5 | < 0.0001 |
| Duration of COVID symptoms before inclusion [days] | 17 (12–27) | – | – | 10 (9–11) | – | – |
| Days from ICU admission to inclusion [days] | 7 (4–12) | – | – | 2 (1–3) | – | – |
| O2 saturation [%] | 93 ± 3 | – | – | 92 ± 10 | 98 ± 1 | 0.0006 |
| PaO2 [mmHg] | 77 ± 24 | – | – | 84 ± 21 | 95 ± 8 | < 0.0001 |
| FiO2 [%] | 48 ± 17 | 21 ± 0 | < 0.0001 | 51 ± 18 | 21 ± 0 | < 0.0001 |
| PaO2/FiO2 ratio | 178 ± 79 | – | – | 187 ± 67 | 454 ± 38 | < 0.0001 |
| PEEP [cmH2O] | 15.7 ± 6.9 | – | – | 11.5 ± 4.1 | – | – |
| pH | 7.39 ± 0.08 | – | – | 7.39 ± 0.07 | 7.44 ± 0.02 | < 0.0001 |
| Lactate [mmol L−1] | 1.2 ± 0.4 | – | – | 2.1 ± 0.7 | 0.8 ± 0.2 | < 0.0001 |
| Hemoglobin [g L−1] | 97 ± 18 | – | – | 127 ± 14 | 148 ± 9 | < 0.0001 |
| Systemic hematocrit [%] | 31 ± 5 | – | – | 39 ± 4 | 43 ± 3 | < 0.0001 |
| Heart rate [bpm] | 92 ± 19 | 69.3 ± 12.1 | < 0.0001 | 69 ± 17 | 59.2 ± 5.3 | 0.001 |
| Mean arterial pressure [mmHg] | 85 ± 12 | 85.8 ± 8.19 | 0.32 | 80 ± 11 | 89.6 ± 9.6 | 0.0001 |
| Full anticoagulation | 23/42 (55%) | 0/40 (0%) | < 0.0001 | 7/21 (33%) | 0/33 (0%) | < 0.0001 |
| Prophylactic anticoagulation | 19/42 (45%) | 0/40 (0%) | < 0.0001 | 14/21 (67%) | 0/33 (0%) | < 0.0001 |
| Pulmonary embolism or macro-thrombosis during ICU stay | 19/39 (49%) | – | – | 4/19 (21%) | – | – |
| ICU mortality | 10/44 (23%) | – | – | 7/21 (33%) | – | – |
| Total vessel density, TVD [mm mm−2] | 21.8 ± 5.2 | 19.2 ± 4.1 | < 0.0001 | 22.6 ± 3.7 | 19.1 ± 4.3 | < 0.0001 |
| Functional capillary density, FCD [mm mm−2] | 21.2 ± 4.9 | 18.2 ± 3.8 | < 0.0001 | 21.6 ± 3.6 | 18.3 ± 4.1 | < 0.0001 |
| Red blood cell velocity, RBCv [μm s−1] | 349 ± 41 | 325 ± 49 | < 0.0001 | 336 ± 35 | 316 ± 52 | < 0.0001 |
| Capillary hematocrit, cHct [%] | 5.17 ± 1.21 | 5.18 ± 0.87 | < 0.0001 | 5.21 ± 0.81 | 4.62 ± 0.83 | < 0.0001 |
Values are given as mean ± SD or median (interquartile range), as appropriate. FiO2, inspiratory oxygen fraction; ICU, intensive care unit; PaO2, arterial oxygen partial pressure; PEEP, positive end-expiratory pressure
Fig. 1Sublingual handheld vital microscopy (HVM) image sequences recorded in four international, multi-central cohorts of critically ill COVID-19 patients and healthy volunteers were used for neuronal network training, model generation and internal validation, and two separate cohorts were used for external validation. Each dataset consisted of the neuronal network input matrix derived from the HVM image sequences, the functional microcirculatory variables derived from the image sequences by algorithm, and the reference COVID-19 disease state categorization. The training dataset was used to train the neuronal network, yielding the deep learning-based model (A), and to calculate the algorithm-based model (B). Both models were evaluated in the internal validation dataset in a bootstrapped process to identify the presence of microcirculatory alterations associated with COVID-19 disease state, and a combined model was calculated and internally validated in a separate, bootstrapped process (C). All models were then externally validated in an independent dataset (D). The results provided by all three models in the internal and external validation dataset were used to calculate the area under the receiver operating characteristic curve in a bootstrapped model, to quantify and compare their performance for identification of the presence of microcirculatory alterations associated with COVID-19 disease state in sublingual microcirculation HVM image sequences. HVM, handheld vital microscopy
Fig. 2Representative examples of time-based mean images of the sublingual microcirculation obtained via handheld vital microscopy in healthy volunteers (A) and critically ill COVID-19 patients (B), and comparison of functional microcirculatory hemodynamic variables in both groups (C). Critically ill COVID-19 patients display disseminated intravascular coagulation (arrow, B left image) and red blood cell microaggregates (arrow, B right image) as previously described [2], representing examples for disease-specific morphological changes with respect to the healthy volunteers. FCD, functional capillary density; RBCv, red blood cell velocity; cHct, capillary hematocrit. Units are [mm mm−2] for FCD, [μm s−1] for RBCv and [%] for cHct
Fig. 3The performance of the algorithm-based, deep learning-based and combined models is demonstrated by the ROC curves for detection of COVID-19 status (A) and the density distributions resulting from the bootstrapped models for AUROC (B). Acceptable AUROC are shown even in the external validation in addition to the high sensitivity and specificity of the models in the internal validation. Dashed gray lines represent the identity line where sensitivity equals (1-specificity). Colored solid vertical lines in (B) represent per-model mean AUROC and colored dashed vertical lines represent the per-model 95% confidence interval of the bootstrapped models for AUROC. AUROC, bootstrap area under the receiver operating characteristic curve; ROC, receiver operating characteristic
Comparison of area under the curve for identification of the presence of microcirculatory alterations associated with COVID-19 status between the algorithm-based, deep learning-based and combined models in internal and external validation
| Model type | AUROC (CI) for identification of COVID-19 status | Linear regression estimates as mean difference ± S.E. (CI) | T statistic and | |||
|---|---|---|---|---|---|---|
| Internal validation cohort | External validation cohort | Between-model comparison | Between-cohort comparison | Between-model comparison | Between-cohort comparison | |
| Algorithm-based model | 0.74 (0.69–0.79) | 0.73 (0.71–0.76) | – | − 0.10 ± 0 .00 (− 0.10 to − 0.10) | – | − 61.88, < 0.0001 |
| Deep learning-based model | 0.81 (0.76–0.86) | 0.61 (0.58–0.63) | − 0.03 ± 0.00 (− 0.03 to − 0.03) | − 15.04, < 0.0001 | ||
| Combined model | 0.84 (0.80–0.89) | 0.75 (0.73–0.78) | 0.06 ± 0.00 (0.06–0.06) | 30.20, < 0.0001 | ||
AUROC bootstrap area under the receiver operating characteristic curve, CI 95% confidence interval, S.E. standard error